Darling Ingredients Inc. (DAR) stock
Close on Oct 30, 2026Market cap $8.79BP/E 15.0Yield –
Earnings
Darling Ingredients's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Darling Ingredients's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Jan 3, 2027 | Feb 10, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 27, 2026 | Oct 28, 2026after the close | $1.80B | +12.5% | $1.67 | – | Release |
| Q2 FY2026ended Jul 4, 2026 | Jul 30, 2026before the open | $1.70B | +13.3% | $2.41 | – | Release |
| Q1 FY2026ended Apr 4, 2026 | Apr 30, 2026before the open | $1.55B | +12.4% | $0.83 | – | Release |
| Q4 FY2025ended Jan 3, 2026 | Feb 11, 2026during market hours | $1.70B | +21.4% | $0.35 | – | Release |
| Q3 FY2025ended Sep 27, 2025 | Oct 23, 2025before the open | $1.60B | +14.3% | $0.12 | – | Release |
| Q2 FY2025ended Jun 28, 2025 | Jul 24, 2025before the open | $1.50B | 0.0% | $0.08 | – | Release |
| Q1 FY2025ended Mar 29, 2025 | Apr 24, 2025before the open | $1.38B | -1.4% | -$0.16 | $195.80 | Release |
| Q4 FY2024ended Dec 28, 2024 | Feb 6, 2025before the open | $1.40B | -12.5% | $0.63 | – | Release |
| Q3 FY2024ended Sep 28, 2024 | Oct 24, 2024before the open | $1.40B | -12.5% | $0.11 | – | Release |
| Q2 FY2024ended Jun 29, 2024 | Jul 25, 2024before the open | $1.50B | -16.7% | $0.49 | – | Release |
| Q1 FY2024ended Mar 30, 2024 | Apr 25, 2024before the open | $1.40B | -22.2% | $0.50 | – | Release |
| Q4 FY2023ended Dec 30, 2023 | Feb 27, 2024during market hours | $1.60B | -11.1% | $0.52 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023during market hours | $1.60B | -5.9% | $0.77 | – | Release |
| Q2 FY2023ended Jul 1, 2023 | Aug 8, 2023during market hours | $1.80B | +9.1% | $1.55 | – | Release |
| Q1 FY2023ended Apr 1, 2023 | May 9, 2023during market hours | $1.80B | +31.4% | $1.14 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 27, 2023during market hours | $1.80B | +38.5% | $0.96 | – | Release |
| Q3 FY2022ended Oct 1, 2022 | Nov 8, 2022during market hours | $1.70B | +41.7% | $1.17 | – | Release |
| Q2 FY2022ended Jul 2, 2022 | Aug 9, 2022during market hours | $1.65B | – | $1.23 | – | Release |
| Q1 FY2022ended Apr 2, 2022 | May 10, 2022during market hours | $1.37B | – | $1.14 | – | Release |
| Q4 FY2021ended Jan 1, 2022 | Feb 28, 2022during market hours | $1.30B | – | $0.94 | – | Release |
| Q3 FY2021ended Oct 2, 2021 | Nov 9, 2021during market hours | $1.20B | – | $0.88 | – | Release |
| Q2 FY2021ended Jul 3, 2021 | Aug 10, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Apr 3, 2021 | May 11, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Jan 2, 2021 | Mar 2, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 26, 2020 | Nov 3, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Darling Ingredients's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Combined Adjusted EBITDAnon-GAAP | FY2026 | $2.20B – $2.30B | – | New | Oct 28, 2026 |
| capital expenditures | FY2026 | $450.00M | – | New | Oct 28, 2026 |
| capital expenditures | FY2026 | $450.00M | $400.00M | Raised | Jul 30, 2026 |
Guidance history
Every forecast Darling Ingredients put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | capital expenditures | FY2026 | $450.00M | New |
| Oct 28, 2026 | Combined Adjusted EBITDA | FY2026 | $2.20B – $2.30B | New |
| Jul 30, 2026 | capital expenditures | FY2026 | $450.00M | Raised |
| Jul 30, 2026 | core ingredients business Adjusted EBITDA | Q3 FY2026 | $325.00M – $340.00M | New |
| Apr 30, 2026 | capital expenditures | FY2026 | $400.00M | New |
| Apr 30, 2026 | core ingredients business Adjusted EBITDA | Q2 FY2026 | $260.00M – $275.00M | New |
| Feb 11, 2026 | core ingredients business adjusted EBITDA | Q1 FY2026 | $240.00M – $250.00M | New |
| Oct 23, 2025 | core ingredients (all segments excluding DGD) Adjusted EBITDA | FY2025 | $875.00M – $900.00M | New |
| Jul 24, 2025 | Combined Adjusted EBITDA | FY2025 | $1.05B – $1.10B | Lowered |
| Apr 24, 2025 | Combined Adjusted EBITDA | FY2025 | $1.25B – $1.30B | Reaffirmed |
| Feb 6, 2025 | Combined Adjusted EBITDA | FY2025 | $1.25B – $1.30B | New |
| Oct 24, 2024 | combined adjusted EBITDA | FY2024 | $1.15B – $1.18B | Lowered |
| Jul 25, 2024 | combined adjusted EBITDA | FY2024 | $1.30B – $1.40B | Reaffirmed |
| Apr 25, 2024 | combined adjusted EBITDA | FY2024 | $1.30B – $1.40B | New |
| Nov 7, 2023 | combined adjusted EBITDA | FY2023 | $1.60B – $1.70B | Lowered |
| Aug 8, 2023 | combined adjusted EBITDA | FY2023 | $1.88B | Reaffirmed |
| May 9, 2023 | combined adjusted EBITDA | FY2023 | $1.88B | Raised |
| Feb 27, 2023 | combined adjusted EBITDA | FY2023 | $1.80B – $1.85B | New |
| Nov 8, 2022 | combined adjusted EBITDA | FY2022 | $1.55B – $1.60B | Reaffirmed |
| Aug 9, 2022 | combined adjusted EBITDA | FY2022 | $1.55B – $1.60B | Reaffirmed |
| May 10, 2022 | combined adjusted EBITDA | FY2022 | $1.55B – $1.60B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Darling Ingredients filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results